Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 64

1.

The use of propolis as vaccine's adjuvant.

Ashry el SH, Ahmad TA.

Vaccine. 2012 Dec 17;31(1):31-9. doi: 10.1016/j.vaccine.2012.10.095. Review.

PMID:
23137844
2.

Synthetic adjuvants for vaccine formulations: phytol derivatives.

Ghosh SK, Chowdhury RR.

Expert Opin Drug Deliv. 2013 Apr;10(4):437-50. doi: 10.1517/17425247.2013.757591. Review.

PMID:
23293963
3.

Combination adjuvants: the next generation of adjuvants?

Mutwiri G, Gerdts V, van Drunen Littel-van den Hurk S, Auray G, Eng N, Garlapati S, Babiuk LA, Potter A.

Expert Rev Vaccines. 2011 Jan;10(1):95-107. doi: 10.1586/erv.10.154. Review.

PMID:
21162624
4.

On vaccine's adjuvants and autoimmunity: Current evidence and future perspectives.

Pellegrino P, Clementi E, Radice S.

Autoimmun Rev. 2015 Oct;14(10):880-8. doi: 10.1016/j.autrev.2015.05.014. Review.

PMID:
26031899
5.

Design and selection of vaccine adjuvants: animal models and human trials.

Alving CR.

Vaccine. 2002 May 31;20 Suppl 3:S56-64. Review.

PMID:
12184368
6.

Selection of potent immunological adjuvants for vaccine construction.

McElrath MJ.

Semin Cancer Biol. 1995 Dec;6(6):375-85. Review.

PMID:
8938276
7.

Adjuvant activities of saponins from traditional Chinese medicinal herbs.

Song X, Hu S.

Vaccine. 2009 Aug 6;27(36):4883-90. doi: 10.1016/j.vaccine.2009.06.033. Review.

PMID:
19559122
8.

New horizons in adjuvants for vaccine development.

Reed SG, Bertholet S, Coler RN, Friede M.

Trends Immunol. 2009 Jan;30(1):23-32. doi: 10.1016/j.it.2008.09.006. Review.

PMID:
19059004
9.

The development and use of vaccine adjuvants.

Edelman R.

Mol Biotechnol. 2002 Jun;21(2):129-48. Review.

PMID:
12059113
10.

Trends in vaccine adjuvants.

Schijns VE, Lavelle EC.

Expert Rev Vaccines. 2011 Apr;10(4):539-50. doi: 10.1586/erv.11.21. Review.

PMID:
21506650
11.

Recent advances in vaccine adjuvants for systemic and mucosal administration.

O'Hagan DT.

J Pharm Pharmacol. 1998 Jan;50(1):1-10. Review.

PMID:
9504429
12.

Vaccine adjuvant systems: enhancing the efficacy of sub-unit protein antigens.

Perrie Y, Mohammed AR, Kirby DJ, McNeil SE, Bramwell VW.

Int J Pharm. 2008 Dec 8;364(2):272-80. doi: 10.1016/j.ijpharm.2008.04.036. Review.

PMID:
18555624
13.

Vaccine adjuvants: role and mechanisms of action in vaccine immunogenicity.

Marciani DJ.

Drug Discov Today. 2003 Oct 15;8(20):934-43. Review.

PMID:
14554157
14.

Adjuvants and autoimmunity.

Israeli E, Agmon-Levin N, Blank M, Shoenfeld Y.

Lupus. 2009 Nov;18(13):1217-25. doi: 10.1177/0961203309345724. Review.

PMID:
19880572
15.

Lipid and carbohydrate based adjuvant/carriers in immunology.

McGeary RP, Olive C, Toth I.

J Pept Sci. 2003 Jul;9(7):405-18. Review.

PMID:
12916638
16.

New adjuvants for human vaccines.

Mbow ML, De Gregorio E, Valiante NM, Rappuoli R.

Curr Opin Immunol. 2010 Jun;22(3):411-6. doi: 10.1016/j.coi.2010.04.004. Review.

PMID:
20466528
17.

Mucosal adjuvants and delivery systems for protein-, DNA- and RNA-based vaccines.

Vajdy M, Srivastava I, Polo J, Donnelly J, O'Hagan D, Singh M.

Immunol Cell Biol. 2004 Dec;82(6):617-27. Review.

18.

Communicating the role and value of vaccine adjuvants.

Gellin BG, Salisbury DM.

Vaccine. 2015 Jun 8;33 Suppl 2:B44-6. doi: 10.1016/j.vaccine.2015.02.073. Review.

PMID:
26022567
19.

Smart adjuvants.

Schmidt CS, Morrow WJ, Sheikh NA.

Expert Rev Vaccines. 2007 Jun;6(3):391-400. Review.

PMID:
17542754
20.

MF59. Design and evaluation of a safe and potent adjuvant for human vaccines.

Ott G, Barchfeld GL, Chernoff D, Radhakrishnan R, van Hoogevest P, Van Nest G.

Pharm Biotechnol. 1995;6:277-96. Review.

PMID:
7551221
Items per page

Supplemental Content

Support Center